FDA Investigator Niraj R Mehta, PhD
Niraj R Mehta, PhD has conducted inspections on 7 sites in 2 countries as of 19 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
19 Jan 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
China
FDA Investigators that have inspected at least one site in common with Niraj R Mehta, PhD:
Alberto A Viciedo,
Allen Lou,
Amanda E Lewin, PhD,
Amy L Singer,
Ana S Cabrera,
Andrea A Branche,
Anita R Michael,
Ann Marie Montemurro,
Arindam Dasgupta, PhD,
Barbara A Rusin,
Barbara L Rellahan, PhD,
Byron Ho, DVM,
Byungja E Marciante,
Cara M Minelli,
Carol Rivera Lopez, PhD,
Charles A Snipes, PhD,
Chelsea W Lamm,
Corey K Reno,
Cynthia A Harris, MD, RN,
Cynthia White,
Daniel J Grabicki,
Dawn C Olenjack,
Deborah B Nixon,
Debra Lboyd Seale,
Dina A Tallman,
Douglas C Kovacs,
Douglas W Gronski,
Dr. Abhijit Raha, PhD,
Dr. Hansong Chen, PhD,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dylan D Yao, MD, PhD,
Eric J Cunningham,
Eric Rothschild,
Eric S Pittman,
Erin D Mccaffery,
Erin L Mcfiren,
Francis J Eng,
Gajendiran Mahadevan, PhD,
Helen B Ricalde,
Helen Verdel,
Jacqueline Mdiaz Albertini,
Jean M Kelahan,
Joseph F Mcginnis, RPh,
Joseph L Despins, PhD,
Joseph R Haynes,
Joy Rkozlowski Klena,
Kara A Scheibner, PhD,
Karen E D'orazio,
Kelli F Dobilas,
Li Li,
Liatte Kreuger, PharmD,
Marijo B Kambere, PhD,
Marion W Nadeau,
Melba Trivera Clavell,
Michael F Skelly, PhD,
Michael Serrano,
Mike M Rashti,
Mohsen Rajabi Abhari, FDA,
Nancy A Bellamy,
Nancy L Rolli,
Natalie A Mickelsen, DVM,
Nicola M Fenty Stewart,
Paul L Bellamy,
Peter R Lenahan,
Prabhu P Raju,
Regina T Brown,
Sandra Kershaw,
Sarah Adella Fave,
Shirley H Isbill,
Sidney B Priesmeyer,
Sinai I Davis,
Sripal R Mada, PhD,
Stanley Au,
Stephanie Mangigian, MS/OSH, RN,
Thomas J Arista,
Tracey Asinjen Wiersma,
Wayne J Meyer,
William D Tingley,
William H Taylor,
Xikui Chen (nmi), PhD
Niraj R Mehta, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2013 | FDA 483 | Hoffmann La Roche Inc - Form 483, 2013-05-09 |
December, 2012 | FDA 483 | University of Maryland School of Medicine - Form 483, 2013-01-04 |
June, 2013 | FDA 483 | QPS, LLC - Form 483, 2013-06-21 |
June, 2013 | EIR | QPS, LLC - EIR, 2013-06-21 |
May, 2013 | EIR | Hoffmann La Roche Inc - EIR, 2013-05-09 |
October, 2014 | FDA 483 | Charles River Laboratories - Form 483, 2014-10-10 |
June, 2013 | FDA 483 Response | QPS, LLC - Form 483R, 2013-07-11 |
September, 2013 | FDA 483 | Joinn Laboratories Co. Ltd. - Form 483, 2013-09-20 |
July, 2013 | EIR | StageBio - EIR, 2013-07-19 |
July, 2013 | FDA 483 | StageBio - Form 483, 2013-07-25 |
September, 2013 | FDA 483 | Pharmaron - Form 483, 2013-09-13 |
December, 2012 | EIR | University of Maryland School of Medicine - EIR, 2012-12-14 |
October, 2014 | EIR | Charles River Laboratories - EIR, 2014-10-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more